MiRNAs and estrogen action

Trends in Endocrinology and Metabolism

Volumn 23, Issue 5, 2012, Pages 223-233

  Klinge, Carolyn M ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRADIOL RECEPTOR; MICRORNA;

BREAST CANCER; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; GENE EXPRESSION; GENETIC REGULATION; HORMONAL REGULATION; HUMAN; MAMMARY GLAND; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; UTERUS;

ANIMALS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HUMANS; MALE; MICRORNAS; MODELS, BIOLOGICAL;

EID: 84860386584     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2012.03.002     Document Type: Review

References (100)

1. Kapranov P., et al. The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA. BMC Biol. 2010, 8:149.
2. Wery M., et al. Noncoding RNAs in gene regulation. Wiley Interdiscip. Rev. Syst. Biol. Med. 2011, 3:728-738.
3. Zeng Y. Principles of micro-RNA production and maturation. Oncogene 2006, 25:6156-6162.
4. Hinske L., et al. A potential role for intragenic miRNAs on their hosts' interactome. BMC Genomics 2010, 11:533.
5. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011, 39:D152-D157.
6. Iorio M.V., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65:7065-7070.
7. Adams B.D., et al. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol. Endocrinol. 2007, 21:1132-1147.
8. Nothnick W.B., Healy C. Estrogen induces distinct patterns of microRNA expression within the mouse uterus. Reprod. Sci. 2010, 17:987-994.
9. * expression in embryonic chicken gonads. Biol. Reprod. 2011, 85:22-30.
10. Pan Q., et al. Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids. J. Cell. Mol. Med. 2008, 12:227-240.
11. Bhat-Nakshatri P., et al. Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res. 2009, 37:4850-4861.
12. Castellano L., et al. The estrogen receptor-alpha induced microRNA signature regulates itself and its transcriptional response. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:15732-15737.
13. Klinge C.M. Estrogen regulation of microRNA expression. Curr. Genomics 2009, 10:169-183.
14. Wickramasinghe N., et al. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res. 2009, 37:2584-2595.
15. Wang G., et al. RNA Polymerase II binding patterns reveal genomic regions involved in microRNA gene regulation. PLoS ONE 2010, 5:e13798.
16. Katchy A., et al. Estradiol-activated estrogen receptor α does not regulate mature microRNAs in T47D breast cancer cells. J. Steroid Biochem. Mol. Biol. 2012, 128:145-153.
17. Cittelly D.M., et al. Downregulation of miR-342 is associated with tamoxifen resistant breast tumors. Mol. Cancer 2010, 9:317.
18. Cicatiello L., et al. Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs. Am. J. Pathol. 2010, 176:2113-2130.
19. Masri S., et al. The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells. Breast Cancer Res. Treat. 2010, 124:89-99.
20. Rao X., et al. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene 2011, 30:1082-1097.
21. Zhang R., et al. Estrogen receptor-regulated microRNAs contribute to the BCL2/BAX imbalance in endometrial adenocarcinoma and precancerous lesions. Cancer Lett. 2012, 314:155-165.
22. Cochrane D., et al. MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer. Horm. Cancer 2010, 1:306-319.
23. Yamagata K., et al. Maturation of microRNA is hormonally regulated by a nuclear receptor. Mol. Cell 2009, 36:340-347.
24. Dai R., et al. Suppression of LPS-induced IFNgamma and nitric oxide in splenic lymphocytes by select estrogen-regulated miRNA: a novel mechanism of immune modulation. Blood 2008, 112:4591-4597.
25. Pan Q., et al. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol. Hum. Reprod. 2007, 13:797-806.
26. Maillot G., et al. Widespread estrogen-dependent repression of microRNAs involved in breast tumor cell growth. Cancer Res. 2009, 69:8332-8340.
27. Hah N., et al. A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell 2011, 145:622-634.
28. Di Leva G., et al. MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J. Natl. Cancer Inst. 2010, 102:706-721.
29. Qian P., et al. Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. Cancer Res. 2011, 71:6463-6474.
30. Manavalan T.T., et al. Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells. Cancer Lett. 2011, 313:26-43.
31. Bergamaschi A., Katzenellenbogen B.S. Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance. Oncogene 2012, 31:39-47.
32. Davis-Dusenbery B.N., Hata A. Mechanisms of control of microRNA biogenesis. J. Biochem. (Tokyo) 2010, 148:381-392.
33. Suzuki H.I., Miyazono K. Emerging complexity of microRNA generation cascades. J. Biochem. (Tokyo) 2011, 149:15-25.
34. Gregory R.I., et al. The microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240.
35. Fukuda T., et al. DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat. Cell Biol. 2007, 9:604-611.
36. Katahira J., Yoneda Y. Nucleocytoplasmic transport of microRNAs and related small RNAs. Traffic 2011, 12:1468-1474.
37. Cifuentes D., et al. A novel miRNA processing pathway independent of Dicer requires argonaute2 catalytic activity. Science 2010, 328:1694-1698.
38. Lowery A.J., et al. MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. Clin. Cancer Res. 2008, 14:360-365.
39. Djuranovic S., et al. A parsimonious model for gene regulation by miRNAs. Science 2011, 331:550-553.
40. Selbach M., et al. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
41. Chi S., et al. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009, 460:479-486.
42. Vasudevan S., et al. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318:1931-1934.
43. Nelson P.T., et al. Specific sequence determinants of miR-15/107 microRNA gene group targets. Nucleic Acids Res. 2011, 39:8163-8172.
44. Huang S., et al. MicroRNA-181a modulates gene expression of zinc finger family members by directly targeting their coding regions. Nucleic Acids Res. 2010, 38:7211-7218.
45. Qin W., et al. miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS ONE 2010, 5:e9429.
46. Watanabe M., et al. A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO J. 2001, 20:1341-1352.
47. Paris O., et al. Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. Oncogene 2012, 10.1038/onc.2011.583.
48. Paroo Z., et al. Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling. Cell 2009, 139:112-122.
49. Levin E.R. Minireview: extranuclear steroid receptors: roles in modulation of cell functions. Mol. Endocrinol. 2011, 25:377-384.
50. Shao R., et al. Distinct expression pattern of Dicer1 correlates with ovarian-derived steroid hormone receptor expression in human fallopian tubes during ovulation and the midsecretory phase. J. Clin. Endocrinol. Metab. 2011, 96:E869-E877.
51. Adams B.D., et al. Argonaute-2 expression is regulated by EGFR/MAPK signaling and correlates with a transformed phenotype in breast cancer cells. Endocrinology 2009, 150:14-23.
52. Lewis B.P., et al. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
53. Corrada D., et al. myMIR: a genome-wide microRNA targets identification and annotation tool. Brief. Bioinform. 2011, 12:588-600.
54. Pandey D.P., Picard D. miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol. Cell. Biol. 2009, 29:3783-3790.
55. Leivonen S.K., et al. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene 2009, 28:3926-3936.
56. Kondo N., et al. miR-206 expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res. 2008, 68:5004-5008.
57. Chen X., et al. Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma. Cancer Lett. 2012, 314:41-53.
58. Li X., et al. MicroRNA-27a indirectly regulates estrogen receptor alpha expression and hormone responsiveness in MCF-7 breast cancer cells. Endocrinology 2010, 151:2462-2473.
59. Safe S., Kim K. Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J. Mol. Endocrinol. 2008, 41:263-275.
60. Wu F., et al. Role of SP transcription factors in hormone-dependent modulation of genes in MCF-7 breast cancer cells: microarray and RNA interference studies. J. Mol. Endocrinol. 2009, 42:19-33.
61. Yang R., et al. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res. Treat. 2010, 121:693-702.
62. Zhao Y., et al. Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. Breast Cancer Res. Treat. 2011, 127:69-80.
63. Boyerinas B., et al. The role of let-7 in cell differentiation and cancer. Endocr. Relat. Cancer 2010, 17:F19-F36.
64. Al-Nakhle H., et al. Estrogen receptor beta1 expression is regulated by miR-92 in breast cancer. Cancer Res. 2010, 70:4778-4784.
65. Corcoran C., et al. Intracellular and extracellular microRNAs in breast cancer. Clin. Chem. 2011, 57:18-32.
66. Qi L., et al. Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma. BMC Cancer 2009, 9:163.
67. Frankel L.B., et al. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 2008, 283:1026-1033.
68. Si M.L., et al. miR-21-mediated tumor growth. Oncogene 2007, 26:2799-2803.
69. Lu Z., et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008, 27:4373-4379.
70. Iorio M.V., et al. Breast cancer and microRNAs: therapeutic impact. Breast 2011, 20:S63-S70.
71. Henderson B.E., Feigelson H.S. Hormonal carcinogenesis. Carcinogenesis 2000, 21:427-433.
72. Liehr J.G. Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development. Hum. Reprod. Update 2001, 7:273-281.
73. Sasano H., et al. In situ estrogen production and its regulation in human breast carcinoma: from endocrinology to intracrinology. Pathol. Int. 2009, 59:777-789.
74. Nakajima M., Yokoi T. MicroRNAs from biology to future pharmacotherapy: regulation of cytochrome P450s and nuclear receptors. Pharmacol. Ther. 2011, 131:330-337.
75. Sirotkin A.V., et al. Identification of MicroRNAs controlling human ovarian cell steroidogenesis via a genome-scale screen. J. Cell. Physiol. 2009, 219:415-420.
76. Lydon J.P., O'Malley B.W. Minireview: steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis. Endocrinology 2011, 152:19-25.
77. Hossain A., et al. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol. Cell. Biol. 2006, 26:8191-8201.
78. Adams B.D., et al. The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells. Mol. Endocrinol. 2009, 23:1215-1230.
79. Neuman E., et al. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol. 1997, 17:5338-5347.
80. Yang C., et al. Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. Mol. Cell. Biol. 2010, 30:3111-3125.
81. Yu Z., et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J. Cell Biol. 2008, 182:509-517.
82. Takata A., et al. MicroRNA-22 and microRNA-140 suppress NF-κB activity by regulating the expression of NF-κB coactivators. Biochem. Biophys. Res. Commun. 2011, 411:826-831.
83. Smith C.L., et al. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol. Endocrinol. 1997, 11:657-666.
84. Peterson T.J., et al. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity. Mol. Cell. Biol. 2007, 27:5933-5948.
85. Foley N.H., et al. MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2. Cell Death Differ. 2011, 18:1089-1098.
86. Wu J., et al. MicroRNA-184 downregulates nuclear receptor corepressor 2 in mouse spermatogenesis. BMC Dev. Biol. 2011, 11:64.
87. Farazi T.A., et al. MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res. 2011, 71:4443-4453.
88. Bui-Nguyen T.M., et al. Stimulation of inducible nitric oxide by hepatitis B virus transactivator protein HBx requires MTA1 coregulator. J. Biol. Chem. 2010, 285:6980-6986.
89. Jiang A., et al. miR-615-3p promotes the phagocytic capacity of splenic macrophages by targeting ligand-dependent nuclear receptor corepressor in cirrhosis-related portal hypertension. Exp. Biol. Med. 2011, 236:672-680.
90. Grober O., et al. Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation. BMC Genomics 2011, 12:36.
91. Ring A., Dowsett M. Mechanisms of tamoxifen resistance. Endocr. Relat. Cancer 2004, 11:643-658.
92. Miller T.E., et al. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27(Kip1). J. Biol. Chem. 2008, 283:29897-29903.
93. Xin F., et al. Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance. Bioinformatics 2009, 25:430-434.
94. Zhao J.-J., et al. MicroRNA-221/222 negatively regulates ERalpha and associates with tamoxifen resistance in breast cancer. J. Biol. Chem. 2008, 283:31079-31086.
95. Howe E., et al. The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity. J. Mammary Gland Biol. Neoplasia 2012, 1-13.
96. Cittelly D.M., et al. Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors. Carcinogenesis 2010, 31:2049-2057.
97. Shi W., et al. MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer Res. 2011, 71:2926-2937.
98. Bracken C.P., et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008, 68:7846-7854.
99. Cochrane D.R., et al. Loss of miR-200c: a marker of aggressiveness and chemoresistance in female reproductive cancers. J. Oncol. 2010, 2010:821717.
100. Sachdeva M., et al. MicroRNA-101-mediated Akt activation and estrogen-independent growth. Oncogene 2011, 30:822-831.